Actavis PLC $226.25

up +2.89


21/8/2014 04:03 PM  |  NYSE : ACT  
Industries : Drugs / Drugs - Generic
Get Trend Analysis Icon Get ACT Trend Analysis - it has outperformed the S&P 500 by 45%

Partner Headlines

  1. Pfizer Could Revive AstraZeneca Bid As Early As Tuesday

    Benzinga
  2. Bases Have Different Looks But Share Many Similarities

    IBD
  3. Dow Flirts With 19,000, S&P 500 Approaches 2,000 & Nasdaq Trading At 14-Year ...

    Benzinga
  4. Shares Of Depomed Moving Higher

    Benzinga
  5. Leaders Actavis, Salix Trip Sell Signals

    IBD
  6. Stocks Muted; Keurig Green Mountain Down After Hours

    IBD
  7. Drugmaker Q2 Profits Robust

    IBD
  8. 4 Top-Rated Drugmakers Beat Q2 Earnings Estimates

    IBD
  9. Actavis Guidance Disappoints; Akorn Beats And Raises

    IBD
  10. UPDATE: Actavis Posts Upbeat Q2 Earnings, Raises Forecast

    Benzinga
  11. Earnings Scheduled For August 5, 2014

    Benzinga
  12. Salix, Actavis Lead IBD 50 Drug Earnings This Week

    IBD
  13. Many Leading Stocks Damaged As Market Tumbles Broadly

    IBD
  14. UPDATE: Bank Of America Reiterates On Actavis plc On Strong Strategic/Financial ...

    Benzinga
  15. Actavis May Give Buyers Another Chance

    IBD
  16. Diamond Hill Capital Comments on Actavis PLC

    GuruFocus
  17. Activis Shares Languish Post-Forest Deal

    Benzinga
  18. George Soros Reveals His Largest Stake

    GuruFocus
  19. Medicines360 And Actavis Announce FDA Acceptance For Filing Of NDA For ...

    Benzinga
  20. Enable Partners, Other Leaders Facing Market Pressure

    IBD
  21. Actavis Looks To Keep Up Momentum In Spite Of Yellen's Report

    Benzinga
  22. Facebook, Apple Suppliers Lead 5 Big-Cap All-Stars

    IBD
  23. Facebook, Apple Suppliers Lead 5 Big-Cap All-Stars

    IBD
  24. Actavis Fuels Growth With Acquisitions, New Generics

    IBD
  25. ACTAVIS

    IBD
  26. Stocks Ease Off Lows; King Digital Turns Tail

    IBD
  27. What Stocks Top Funds Are Buying Now

    IBD
  28. ACTAVIS

    IBD
  29. Markets Little Changed Ahead Of 4th Of July Break

    Benzinga
  30. Many IBD 50 Stocks Struggle To Climb After Breakouts

    IBD
  31. Novo, Other Medicals Display Healthy Action

    IBD
  32. Among A Raft Of Index Changes, Affiliated Managers Group To Join S&P 5 ...

    Benzinga
  33. Diamond Hill Capital Comments on Actavis Inc

    GuruFocus
  34. Diamond Hill Small Cap Fund Commentary - First Quarter 2014

    GuruFocus
  35. Actavis and Forest Announce Tentative Election Deadline of June 27, 2014

    Benzinga
  36. Bulls Take A Break As Dow's Winning Streak Ends At 7 Days

    Benzinga
  37. Major Indexes Narrowly Lower As Actavis Rallies

    IBD
  38. Generic-Drug Makers Climb Ranks; Several In Buy Range

    IBD
  39. M&A Activity Helps Fuel Healthy Action In Drugmakers

    IBD
  40. Market Wrap For June 18: Markets Rally On Fed Comments And Tapering

    Benzinga
  41. Nasdaq, S&P 500 Rally To New Highs After Fed Meeting

    IBD
  42. Stocks Open Mixed In Firm Trade; Adobe, FedEx, Air Products Jump

    IBD
  43. UPDATE: Morgan Stanley Resumes Coverage On Actavis Following Forest Acquisition

    Benzinga
  44. Allergan, Actavis Top Big Cap Pharmas Amid M&A Flurry

    IBD
  45. Actavis Strives To Reduce Borrowing Costs

    IBD
  46. Wells Fargo Initiates Coverage On The Pharmaceutical Space

    Benzinga
  47. Actavis, BitAuto Among Leading World Stocks In Bases

    IBD
  48. Lannett In Buying Range After Breakout From Cup Base

    IBD
  49. Several IBD 50 Names Set Up In Stock Picker's Market

    IBD
  50. Joseph Papa, A Generic CEO With Brand-Name Action

    IBD
Trading Center